Novoron Bioscience, Inc. — Form D
Novoron Bioscience, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-21. The offering totals $12.1M, of which $12.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-21
- Form: D
- Accession: 0001868315-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.1M
- Amount sold: $12.1M
- Investors: 2
- Date of first sale: 2022-12-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-468224
Issuer
- Name: Novoron Bioscience, Inc.
- CIK: 0001868315
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 7770 REGENTS RD., #113319, SAN DIEGO, CA, 92122
- Phone: 858-324-5114
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Shawn Gahr | Director | San Diego, CA |
| MICHAEL GOGUEN | Director | WHITEFISH, MT |
| Travis Stiles | Director | San Diego, CA |
| Shawn Gahr | Executive Officer | San Diego, CA |
| Travis Stiles | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More